Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99


Any time

2019 ( 82 )

2018 ( 589 )

2017 ( 518 )

2016 ( 532 )

Custom range...

Search Results: 1 - 10 of 34462 matches for " Zhou XJ "
All listed articles are free for downloading (OA Articles)
Page 1 /34462
Display every page Item
Biocompatibility of magnetic Fe3O4 nanoparticles and their cytotoxic effect on MCF-7 cells
Chen DZ, Tang QS, Li XD, Zhou XJ, Zang J, Xue WQ, Xiang JY, Guo CQ
International Journal of Nanomedicine , 2012, DOI: http://dx.doi.org/10.2147/IJN.S35140
Abstract: iocompatibility of magnetic Fe3O4 nanoparticles and their cytotoxic effect on MCF-7 cells Original Research (2298) Total Article Views Authors: Chen DZ, Tang QS, Li XD, Zhou XJ, Zang J, Xue WQ, Xiang JY, Guo CQ Published Date September 2012 Volume 2012:7 Pages 4973 - 4982 DOI: http://dx.doi.org/10.2147/IJN.S35140 Received: 19 June 2012 Accepted: 01 August 2012 Published: 14 September 2012 Daozhen Chen,1,3,* Qiusha Tang,2,* Xiangdong Li,3,* Xiaojin Zhou,1 Jia Zang,1 Wen-qun Xue,1 Jing-ying Xiang,1 Cai-qin Guo1 1Central Laboratory, Wuxi Hospital for Matemaland Child Health Care Affiliated Medical School of Nanjing, Jiangsu Province; 2Department of Pathology and Pathophysiology, Medical College, Southeast University, Jiangsu Province; 3The People’s Hospital of Aheqi County, Xinjiang, China *These authors contributed equally to this work Background: The objective of this study was to evaluate the synthesis and biocompatibility of Fe3O4 nanoparticles and investigate their therapeutic effects when combined with magnetic fluid hyperthermia on cultured MCF-7 cancer cells. Methods: Magnetic Fe3O4 nanoparticles were prepared using a coprecipitation method. The appearance, structure, phase composition, functional groups, surface charge, magnetic susceptibility, and release in vitro were characterized by transmission electron microscopy, x-ray diffraction, scanning electron microscopy-energy dispersive x-ray spectroscopy, and a vibrating sample magnetometer. Blood toxicity, in vitro toxicity, and genotoxicity were investigated. Therapeutic effects were evaluated by MTT [3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide] and flow cytometry assays. Results: Transmission electron microscopy revealed that the shapes of the Fe3O4 nanoparticles were approximately spherical, with diameters of about 26.1 ± 5.2 nm. Only the spinel phase was indicated in a comparison of the x-ray diffraction data with Joint Corporation of Powder Diffraction Standards (JCPDS) X-ray powder diffraction files. The O-to-Fe ratio of the Fe3O4 was determined by scanning electron microscopy-energy dispersive x-ray spectroscopy elemental analysis, and approximated pure Fe3O4. The vibrating sample magnetometer hysteresis loop suggested that the Fe3O4 nanoparticles were superparamagnetic at room temperature. MTT experiments showed that the toxicity of the material in mouse fibroblast (L-929) cell lines was between Grade 0 to Grade 1, and that the material lacked hemolysis activity. The acute toxicity (LD50) was 8.39 g/kg. Micronucleus testing showed no genotoxic effects. Pathomorphology and blood biochemistry testing demonstrated that the Fe3O4 nanoparticles had no effect on the main organs and blood biochemistry in a rabbit model. MTT and flow cytometry assays revealed that Fe3O4 nano magnetofluid thermotherapy inhibited MCF-7 cell proliferation, and its inhibitory effect was dose-dependent according to the Fe3O4 nano magnetofluid concentration. Conclusion: The Fe3O4 nanopart
Age of the Early Devonian Kangbutiebao Formation along the southern Altay Mountains and its northeastern extension

Liu W,Liu LJ,Liu XJ,Shang HJ,Zhou G,

岩石学报 , 2010,
Abstract: 麦兹火山-沉积盆地康布铁堡组的年龄及其东界,以及阿尔泰南缘早泥盆世火山活动往东往北延伸的范围仍然没有确定; 康布铁堡组火山岩的源岩及其形成的构造环境还有待阐明。近年来在麦兹盆地东侧发现了萨吾斯铅锌矿床,矿床赋存于康布铁堡组火山岩,与别斯萨拉玢岩体密切有关。本研究对萨吾斯铅锌矿床的康布铁堡组流纹岩和别斯萨拉玢岩进行了SIMS锆石U-Pb定年以及主微量元素组成测定,以期回答上述问题。流纹岩锆石的18个靶点给出了一致的谐和年龄和加权平均年龄(401Ma); 花岗闪长玢岩锆石的15个靶点给出了一致的谐和年龄和加权平均年龄(401Ma)。因此,萨吾斯铅锌矿床康布铁堡组流纹岩和别斯萨拉玢岩是同期喷发/侵入的; 康布铁堡组火山活动的时代在早泥盆世; 麦兹火山-沉积盆地的东界应抵达卡拉先格尔断裂西侧。在~400Ma时期,阿尔泰地区不仅存在着广泛的花岗岩类深成岩浆活动,也发生了强烈的酸性火山喷发,两者共同构成了阿尔泰南缘的大陆边缘岩浆弧。但是,火山喷发主要集中于阿尔泰南缘,受断裂控制。花岗闪长玢岩的一些锆石给出513.8Ma和3134Ma的U-Pb年龄,反映区内陆壳由寒武纪-奥陶纪岩石组成,并且还有前寒武纪微陆块。硅-碱、SiO2-K2O、log τ-log σ、SiO2-FeO/(FeO+MgO)图以及构造环境判别图表明,萨吾斯铅锌矿床的流纹岩、凝灰岩、石英闪长玢岩-花岗闪长玢岩以及阿尔泰南缘早泥盆世康布铁堡组火山岩形成于活动大陆边缘或岛弧环境。康布铁堡组中下段细碧角斑岩在岛弧海底环境喷发,上段流纹岩喷发于大陆边缘环境。原始地幔标准化的多元素蛛网图表明,萨吾斯矿床的三类岩石具有明显的Nb、Ta、Ti和Sr、P、Ba负异常,显著富集Th、U、K、La、Ce、Pr、Zr、Hf。结合锆石U-Pb年龄,作者认为它们的源岩应以寒武纪-奥陶纪的岛弧岩石为主; 同时,可能还含有一定比例的前寒武纪古老陆壳岩石。冲乎尔、克兰、麦兹三个火山-沉积盆地在所属构造单元、陆壳基底、火山岩岩石地球化学以及沉积岩的比例上都表现出系统变化,这些变异控制了阿尔泰南缘块状硫化物矿床从西部到中部到东部的成矿元素组合上的变化。
XJ Liu,

金属学报(英文版) , 1997,
Abstract: In this paper a concept of "leading probability" is presented. The difference in the leading probability between ferrite and cementite depends mainly upon the difference between their driving forces at the beginning of precipitation. The results of theromdynamic calculations showed that the leading probability of cementite increased with the increase of carbon concentration of austenite, and the decrease in transformation temperature was favourable to cementite's being the leading nucleus during pearlite transformation.
Study on Design Techniques of a Long Life Hot Forging Die with Multi-Materials

XJ Liu,HC Wang,and DW Li,

金属学报(英文版) , 2007,
Abstract: A new design technique for the long life hot forging die has been proposed. By finite elementanalysis, the reason for the failure of hot forging die was analyzed and it was concluded thatthermal stress is the main reason for the failure of hot forging die. Based on this conclusion, thewhole hot forging die was divided into the substrate part and the heat-resistant part accordingto the thermal stress distribution. Moreover, the heat-resistant part was further subdivided intomore zones and the material of each zone was reasonably selected to ensure that the hotforging die can work in an elastic state. When compared with the existing techniques, this design cangreatly increase the service life because the use of multi-materials can alleviate the thermalstress in hot forging die.
Cancer care in China: A general review
XJ Ma,C Lin,W Zhen
Biomedical Imaging and Intervention Journal , 2008, DOI: 10.2349/biij.4.3.e39
Syphilis in China: the great comeback
WX Zhu,XJ Ye,T Hesketh
Emerging Health Threats Journal , 2008, DOI: 10.3134/ehtj.08.006
Abstract: China is currently witnessing a major resurgence of syphilis from the elimination of the disease in the 1960s to 5.3 per 100,000 people incidence in 2000-2005. The reasons for the elimination and subsequent resurgence of syphilis in China lie at the heart of much public health debate, highlighting both the relationship between politics and public health, and the role of government in controlling disease. Were the Draconian measures to control syphilis during the early Mao years a price worth paying for the effective control? Is the recent resurgence of syphilis an inevitable consequence of economic development and greater freedom for the individual, which will ultimately lead to better health for the majority of the population? Could tougher control measures such as those of the early Mao years be re-introduced in the current social and economic climate in China? In this review, we briefly chart the history of the syphilis epidemic in China, its elimination in the 1960s, and its gradual resurgence in the past two decades. We explore the reasons for this resurgence, and we conclude with a discussion on the options for control.
Inflammatory Myofibroblastic Tumor Presenting as a Pancreatic Mass: A Case Report and Review of the Literature
Pungpapong S,Geiger XJ,Raimondo M
JOP Journal of the Pancreas , 2004,
Abstract: CONTEXT: Inflammatory myofibroblastic tumor is a distinctive lesion of unknown etiology. It has generally been considered a rare benign pseudosarcomatous lesion of admixed inflammatory infiltrates with myofibroblastic spindle cells. Although original case descriptions focused on the pulmonary system, it is now recognized that virtually any anatomic location can be involved. However, an inflammatory myofibroblastic tumor located in the pancreas is rare. CASE REPORT: We report a case of an asymptomatic 70-year-old Caucasian man with a 3.8 cm inflammatory myofibroblastic tumor located in the tail of the pancreas which was discovered incidentally on a computed tomography scan of the abdomen. Endoscopic ultrasonography with fine needle aspiration was negative for malignancy. However, because of worrisome radiographic features, a distal pancreatectomy with splenectomy was performed. The pathology revealed an inflammatory myofibroblastic tumor with focal extension into the peripancreatic soft tissues, but with negative surgical margins. The patient has been followed for 10 months without evidence of recurrence. CONCLUSIONS: To date, there have been only 25 cases of inflammatory myofibroblastic tumor located in the pancreas reported in the English language scientific literature. Even with multimodal pre-surgical investigation, it can be extremely difficult to differentiate inflammatory myofibroblastic tumor from pancreatic malignancies. Most cases require surgical exploration and complete resection to obtain an accurate diagnosis. A review of published case reports is also presented.
Construction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)- 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity
Ma X, Wang H, Jin S, Wu Y, Liang XJ
International Journal of Nanomedicine , 2012, DOI: http://dx.doi.org/10.2147/IJN.S29371
Abstract: nstruction of paclitaxel-loaded poly (2-hydroxyethyl methacrylate)-g-poly (lactide)- 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine copolymer nanoparticle delivery system and evaluation of its anticancer activity Original Research (3241) Total Article Views Authors: Ma X, Wang H, Jin S, Wu Y, Liang XJ Published Date March 2012 Volume 2012:7 Pages 1313 - 1328 DOI: http://dx.doi.org/10.2147/IJN.S29371 Received: 21 December 2011 Accepted: 24 January 2012 Published: 07 March 2012 Xiaowei Ma*, Huan Wang*, Shubin Jin, Yan Wu, Xing-Jie Liang Laboratory of Nanomedicine and Nanosafety, Division of Nanomedicine and Nanobiology, National Center for Nanoscience and Technology, People’s Republic of China; and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Chinese Academy of Sciences, Beijing, People’s Republic of China *These authors contributed equally to this work Background: There is an urgent need to develop drug-loaded biocompatible nanoscale packages with improved therapeutic efficacy for effective clinical treatment. To address this need, a novel poly (2-hydroxyethyl methacrylate)-poly (lactide)-1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine [PHEMA-g-(PLA-DPPE)] copolymer was designed and synthesized to enable these nanoparticles to be pH responsive under pathological conditions. Methods: The structural properties and thermal stability of the copolymer was measured and confirmed by Fourier transform infrare d spectroscopy, nuclear magnetic resonance, and thermogravimetric analysis. In order to evaluate its feasibility as a drug carrier, paclitaxel-loaded PHEMA-g-(PLA-DPPE) nanoparticles were prepared using the emulsion-solvent evaporation method. Results: The PHEMA-g-(PLA-DPPE) nanoparticles could be efficiently loaded with paclitaxel and controlled to release the drug gradually and effectively. In vitro release experiments demonstrated that drug release was faster at pH 5.0 than at pH 7.4. The anticancer activity of the PHEMA-g-(PLA-DPPE) nanoparticles was measured in breast cancer MCF-7 cells in vivo and in vitro. In comparison with the free drug, the paclitaxel-loaded PHEMA-g-(PLA-DPPE) nanoparticles could induce more significant tumor regression. Conclusion: This study indicates that PHEMA-g-(PLA-DPPE) nanoparticles are promising carriers for hydrophobic drugs. This system can passively target cancer tissue and release drugs in a controllable manner, as determined by the pH value of the area in which the drug accumulates.
Expression of transient receptor potential channel 6 in cervical cancer
Wan Q, Zheng A, Liu XJ, Chen YL, Han L
OncoTargets and Therapy , 2012, DOI: http://dx.doi.org/10.2147/OTT.S33550
Abstract: ession of transient receptor potential channel 6 in cervical cancer Original Research (1031) Total Article Views Authors: Wan Q, Zheng A, Liu XJ, Chen YL, Han L Published Date September 2012 Volume 2012:5 Pages 171 - 176 DOI: http://dx.doi.org/10.2147/OTT.S33550 Received: 03 May 2012 Accepted: 24 July 2012 Published: 07 September 2012 Qi Wan,1 Ai Zheng,1 Xiaojing Liu,2 Yali Chen,1 Ling Han1 1Department of Obstetric and Gynecology, West China Second University Hospital, 2Laboratory of Cardiovascular Diseases, Regenerative Medicine Research Center, West China Hospital, Sichuan University, Chengdu, China Background: Recent studies have reported that aberrant expression of transient receptor potential channel C6 (TRPC6) in a variety of human cancers is associated with aggressive behavior. However, the functional significance of TRPC6 in human cervical cancer is not known. This study was planned to detect whether TRPC6 is expressed in cervical cancer tissue and to evaluate the association between TPRC6 expression and clinicopathologic features. Methods: Tissue samples were collected from the West China Second UNIV Hospital of Sichuan University. TRPC6 expression was detected by quantitative real-time reverse transcription polymerase chain reaction and Western blotting. TRPC6 expression was evaluated by immunohistochemistry analysis of 40 cervical cancer specimens, and correlations were sought between elevated expression of TRPC6 and clinicopathologic features. Results: Increased expression of TRPC6 was detected in 25 of the 40 cervical cancer samples. Positive cells found in cervical carcinomas were significantly increased in numbers compared with specimens without lymphovascular space invasion. Elevated expression of TRPC6 was neither related to International Federation of Gynecology and Obstetrics stage nor pelvic lymph metastases. Indeed, the clinicopathologic analysis indicated that overexpression of TRPC6 was significantly associated with lymphovascular space invasion. Conclusion: These results indicate that elevated expression of TRPC6 might be associated with an aggressive cervical cancer phenotype.
Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK
Wang XJ, Wong SH, Givergis R, Chynn EW
Clinical Ophthalmology , 2011, DOI: http://dx.doi.org/10.2147/OPTH.S24656
Abstract: luation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK Original Research (3250) Total Article Views Authors: Wang XJ, Wong SH, Givergis R, Chynn EW Published Date October 2011 Volume 2011:5 Pages 1451 - 1457 DOI: http://dx.doi.org/10.2147/OPTH.S24656 Xiao Jing Wang, Sze H Wong, Roshan Givergis, Emil W Chynn Park Avenue LASEK, New York, NY, USA Background: To evaluate the analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% compared with ketorolac tromethamine ophthalmic solution 0.5% in laser epithelial keratomileusis (LASEK) or epithelial keratomileusis (epi-LASEK), sometimes referred to as epi-LASIK. Methods: Eighty eyes (from 40 patients, 18 men and 22 women) undergoing bilateral simultaneous LASEK or epi-LASEK were randomized to receive ketorolac in one eye and bromfenac in the other. Mean age was 33.13 ± 9.34 years. One drop of bromfenac or ketorolac was instilled in each eye 15 minutes and one minute prior to surgery, and two and four hours following surgery. Patients were instructed to instill the medications on-label each day through postoperative day 4. The subjects completed pain and visual blurriness assessments from day of surgery to postoperative day 4. Uncorrected visual acuity was tested on postoperative days 1 and 6. Results: For each of the five days, pain scores for bromfenac-treated eyes were significantly less than that for ketorolac-treated eyes (P < 0.01). Of the 40 patients, 32 (80%) said bromfenac provided better postoperative analgesia than ketorolac. There was no statistically significant difference in visual blurriness scores between the two groups (P > 0.1). Uncorrected visual acuity did not vary significantly between the treatment groups (P > 0.1). No serious adverse events were noted. Conclusion: Bromfenac is subjectively superior to ketorolac in reducing postoperative pain following LASEK or epi-LASEK. The subjects tolerated the drugs well with no serious adverse outcomes and no difference in uncorrected visual acuity.
Page 1 /34462
Display every page Item

Copyright © 2008-2017 Open Access Library. All rights reserved.